Sepsis in Cirrhosis INASL 2016
Management of post transplant recurrent hepatitis C infection with directly acting antiviral drugs.
Hepatology International June 2016
NASH in potential healthy liver donors
2016 EASL Barcelona
Predicting fatty liver disease in healthy liver donors
2016 ILTS Seoul
Role of MMF in themanagement of Autoimmune hepatitis
JCEH 2015
Liver regeneration
2015- Textbook Chapter.
Hepatic steatosis in liver donors
EASL 2014 London
BMI and liver transplant outcome
ILTS 2014 London
Liver failure due to rat killer poisoning
ILTS 2014 London
A new era in the management of Hepatitis C infection
Indian Journal of Gastroenterology 2013
Macrophage secretory products induce an inflammatory phenotype in hepatocytes
World Journal of Gastroenerology
Non-invasive assessment of fibrosis in liver grafts due to hepatitis C virus recurrence
Clinical Transplantation
Treatment of autoimmune hepatitis: a review of current and evolving therapies
Journal of Gastroenterology and Hepatology
Early use of TIPS for cirrhosis and variceal bleeding (letter)
NEJM
Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy (letter)
Liver Transplantation
The effect of ethnicity on the presentation and management of oesophageal and gastric cancers: a UK perspective
European Journal of Gastroenterology and Hepatology
Long-term immunosuppression for prevention of nonviral disease recurrence
Transplant Proceedings
Helicobacter heilmanii – Gut associated lymphoma
Gut